| Model Number |
20014 |
| Medical Device Problem Code |
Fluid/Blood Leak (1250)
|
| Health Effect - Clinical Codes |
Hemorrhage/Blood Loss/Bleeding (1888); No Clinical Signs, Symptoms or Conditions (4582)
|
| Date of Event |
04/10/2025
|
|
Type of Reportable Event
|
Malfunction
|
|
Event or Problem Description
|
|
Medtronic received information that during use of a dlp aortic root cannula with a vent line, it was reported that a blood leakage occurred from the connection to the circuit.The cannula was checked, however, there was no particular defects such as cracking or deformation observed.The device was used to complete the procedure.There was no adverse patient effect associated with this event.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Medtronic received additional information that the cannula was not heated or cooled prior to use.There was no noticeable damage in the location of the sutures.No transfusion was required as a result of this leak.Device evaluation summary: visual inspection shows evidence of a void in the bond between the luer connector and the tubing.A syringe filled with deionized water was attached to the device and filled with the water all other openings were sealed.When the syringe was engaged there was a leak observed at the luer fitting/tubing connection.Reason for return was confirmed.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Additional Manufacturer Narrative
|
|
Additional information h6.4 eval code conclusion (fdc/annex d): this field was updated.Correction d.4 unique identifier (udi) #.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|